Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zomedica Pharmaceuticals Corp (NY: ZOM )

0.1312 UNCHANGED
Official Closing Price Updated: 8:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zomedica Pharmaceuticals Corp

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Zomedica Shareholders Vote for the Share Consolidation (Reverse Stock Split)
Via ACCESSWIRE
Zomedica to Host Virtual Investor Day February 13 at 3:00 p.m. ET
Via ACCESSWIRE
3 Hidden-Gem Penny Stocks That Could Yield Life-Changing Wealth
Unlock the secret to wealth with insights on ZOM, SNDL, and BLDE. Discover how these penny stocks could redefine your future. 
Via InvestorPlace
Open Letter to Zomedica Shareholders from your Chief Executive Officer
Via ACCESSWIRE
Zomedica to Participate in the Lytham Partners 2024 Investor Select Conference
Via ACCESSWIRE
Leading Proxy Advisory Firm ISS Recommends Zomedica Shareholders Vote "FOR" Proposed Reverse Stock Split
Via ACCESSWIRE
Zomedica Announces Preliminary 2023 Revenue; Provides Revenue Guidance for 2024, and Rationale for Share Consolidation ("Reverse Stock Split")
Via ACCESSWIRE
3 Breakout Penny Stocks Primed for Massive Gains
Discover three penny stocks poised for breakout success in veterinary, liquor retail, and insurance sectors. 
Via InvestorPlace
Zomedica Corp. to Host Conference Call on January 17, 2024, at 4:30 p.m. ET to Provide a Business Update, Preliminary 2023 Revenue and Cash Position, and Discuss the Proposed Reverse Stock Split; Provides Notice of Special Virtual-Only Meeting of
Via ACCESSWIRE
Budget Bets: Top 3 Penny Stocks with Potential for Explosive Growth
These cheap stocks offer investors an extreme risk to reward tradeoff, which might be worth considering for lucrative payoffs. 
Via InvestorPlace
Zomedica Announces Publication of Research Validating Better Patient Acceptance of PulseVet(R) Electro-hydraulic Shock Wave Therapy without Sedation Utilizing Novel “X-Trode” Handpiece
Via ACCESSWIRE
Zomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of Three New Assays for Commonly Performed Diagnostic Tests for Canine Gastrointestinal Disease
Via ACCESSWIRE
Zomedica Announces Presentation of Clinical Data in Support of New Indications for PulseVet Shock Wave Therapy at Annual Meeting of American Association of Equine Practitioners
Via ACCESSWIRE
Zomedica to Present at Noble Capital Markets' 19th Annual Emerging Growth Equity Conference
Via ACCESSWIRE
Zomedica to Present at the 35th Annual Piper Sandler Healthcare Conference
Via ACCESSWIRE
Zomedica Announces Record Third Quarter 2023 Financial Results: Revenue up 31% to $6.3 Million; 69% Gross Margin, and $118 Million in Liquidity, while Making Strategic Acquisitions of Structured Monitoring Products and Qorvo Biotechnologies
Via ACCESSWIRE
Zomedica to Report Third Quarter 2023 Financial Results and Provide Business Update on November 13 at 4:30 p.m. ET
Via ACCESSWIRE
Zomedica to Participate in the Lytham Partners Fall 2023 Investor Conference
Via ACCESSWIRE
Zomedica Announces Acquisition of TRUFORMA Platform Developer Qorvo Biotech LLC, Accelerating Timeline to Gain Control of Manufacturing and Research & Development
Via ACCESSWIRE
Zomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of First-and-only Point of Care eACTH Assay for Diagnosis and Management of Cushing’s Disease in Horses
Via ACCESSWIRE
Earnings Scheduled For November 13, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter. 
Via Benzinga
Zomedica Provides Corporate Update
Via ACCESSWIRE
7 Biotech Stocks to Sell in September Before They Crash & Burn
These are just a few of the top biotech stocks to sell today - especially with each of the firms dealing with legitimate issues. 
Via InvestorPlace
Zomedica Closes Acquisition of Structured Monitoring Products Adding Revolutionary VetGuardian Touchless Vital Signs Monitor to Product Portfolio
Via ACCESSWIRE
Zomedica to Present at H.C. Wainwright 24th Annual Global Investment Conference
Via ACCESSWIRE
Zomedica Announces Record Second Quarter 2023 Financial Results: Revenue up 43% to $6.0 Million; Strong 67% Gross Margin & $142.4 Million in Liquidity
Via ACCESSWIRE
Earnings Scheduled For August 10, 2023
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million. 
Via Benzinga
Zomedica to Present at Sidoti Virtual Investor Conference August 16-17
Via ACCESSWIRE
Zomedica to Host Second Quarter Financial Results Call on August 10
Via ACCESSWIRE
RedChip Launches 'Small Stocks, Big Money' Podcast
Via ACCESSWIRE
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.